Vifor Intl Drug Patent Portfolio
Vifor Intl owns 1 orange book drug protected by 12 US patents Given below is the list of Vifor Intl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10017536 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US10138270 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US10793596 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US7402564 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US7713937 | Synthetic peptide amides and dimeric forms thereof | 12 Nov, 2027 | Active |
| US7727963 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US8217007 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US8236766 | Uses of synthetic peptide amides | 12 Nov, 2027 | Active |
| US8486894 | Synthetic peptide amides and dimeric forms thereof | 12 Nov, 2027 | Active |
| US8536131 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US9334305 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US9359399 | Synthetic peptide amides | 12 Nov, 2027 | Active |
Latest Legal Activities on Vifor Intl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vifor Intl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US7402564 |
| transaction for FDA Determination of Regulatory Review Period | 28 Nov, 2023 | US7402564 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 06 Oct, 2023 | US10793596 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 07 Aug, 2023 | US8236766 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 12 Jul, 2023 | US8217007 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 12 Jun, 2023 | US9359399 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 11 May, 2023 | US9334305 |
| Second letter to regulating agency to determine regulatory review period | 26 Jan, 2023 | US7402564 |
| Letter from FDA or Dept of Agriculture re PTE application | 28 Sep, 2022 | US7402564 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 26 May, 2022 | US10138270 |
|
Patent Term Extension (156) Dismissed
Critical
| 12 Jan, 2022 | US7402564 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 Jan, 2022 | US10017536 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 19 Nov, 2021 | US7727963 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 10 Nov, 2021 | US7713937 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Mar, 2021 | US8536131 |
Vifor Intl's Family Patents
Vifor Intl drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 45.7% of its total global patent coverage. Click
below to unlock the full patent family tree.
Vifor Intl Drug List
Given below is the complete list of Vifor Intl's drugs and the patents protecting them.
1. Korsuva
Korsuva is protected by 12 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10017536 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(2 years from now)
| Active |
| US10138270 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US10793596 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US7402564 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US7713937 | Synthetic peptide amides and dimeric forms thereof |
12 Nov, 2027
(2 years from now)
| Active |
| US7727963 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US8217007 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US8236766 | Uses of synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
| US8486894 | Synthetic peptide amides and dimeric forms thereof |
12 Nov, 2027
(2 years from now)
| Active |
| US8536131 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(2 years from now)
| Active |
| US9334305 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(2 years from now)
| Active |
| US9359399 | Synthetic peptide amides |
12 Nov, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Korsuva's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List